Guizhou Xinbang Pharmaceutical Co., Ltd. (SHE:002390)

China flag China · Delayed Price · Currency is CNY
3.790
+0.040 (1.07%)
Aug 1, 2025, 2:45 PM CST
1.07%
Market Cap7.19B
Revenue (ttm)5.89B
Net Income (ttm)83.80M
Shares Out1.90B
EPS (ttm)0.04
PE Ratio92.85
Forward PEn/a
Dividend0.06 (1.60%)
Ex-Dividend DateMay 21, 2025
Volume31,790,400
Average Volume20,550,504
Open3.790
Previous Close3.750
Day's Range3.730 - 3.840
52-Week Range2.860 - 4.850
Beta0.45
RSI64.57
Earnings DateAug 30, 2025

About SHE:002390

Guizhou Xinbang Pharmaceutical Co., Ltd. researches, develops, manufactures, and sells Chinese herbal medicines and other pharmaceutical products in China and internationally. The company offers cardiovascular and cerebrovascular, digestive system, endocrine system, etc. It also provides medical services. The company was founded in 1995 and is headquartered in Guiyang, China. [Read more]

Sector Healthcare
Founded 1995
Employees 5,059
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002390
Full Company Profile

Financial Performance

In 2024, SHE:002390's revenue was 6.03 billion, a decrease of -6.63% compared to the previous year's 6.46 billion. Earnings were 101.38 million, a decrease of -64.70%.

Financial Statements

News

There is no news available yet.